How to purchase Dasatinib (Startax) and where to buy it

Dasatinib (Dasatinib) is an oral tyrosine kinase inhibitor that is widely used to treat certain types of leukemia, especially chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

Dasatinib (Dasatinib) is now officially launched in China and has been successfully included in the medical insurance system. Patients can purchase it directly in the country, and the price range is roughly between 4,000 yuan and 5,000 yuan. However, the final price and medical insurance reimbursement ratio are subject to the regulations of your local hospital pharmacy. It is recommended to consult to obtain the most accurate information. In addition, the price of foreign generic drugs of Dasatinib (Startase) is relatively more affordable, only about a few hundred yuan, which has a significant price advantage compared with domestic drugs. It is worth mentioning that whether it is an original drug on the domestic market or a foreign generic drug, their main drug ingredients are basically the same, ensuring the consistency of the drug effect.

As a targeted therapy, dasatinib works by inhibiting the activity of BCR-ABLkinase, an abnormal protein produced by mutations in the Philadelphiachromosome (Phchromosome). This mutation is one of the major causative factors of chronic myelogenous leukemia. By inhibiting the activity of BCR-ABLkinase, dasatinib (Startase) can block the proliferation and growth of abnormal white blood cells, thereby alleviating the condition and extending patient survival.

In addition to treating CML, dasatinib (Startase) is also used to treat certain cases of acute lymphoblastic leukemia, especially those with Ph chromosome positivity.

Compared with traditional chemotherapy drugs, Dasatinib is more selective, so it usually has less toxic effects on normal cells during treatment. However, it may also cause some side effects, including nausea, vomiting, fatigue, headache, edema, etc. In addition, it may also cause some more serious adverse reactions, such as bleeding, arrhythmia, liver function damage, etc. Therefore, the patient's condition and physical condition need to be closely monitored during use.